Mortality caused by tetanus is still a serious health problem in developing countries.Apart from immunization, early treatment with equine antitetanus serum (ATS) or human tetanus immunoglobulin (TIG) is the real treatment that can avoid death. On pathophysiological grounds intrathecal administration would be preferred because of high concentrations of the antiserum in cerebrospinal fluid and thus around the nerve roots. Many studies concluded on its effectiveness whereas others did not find any superiority of this method. However, most of those studies were not random and/or had no sufficient weight.

[Ingredients]Equine tetanus immunoglobulin following pepsin digestion

[Pharmacological action]The product contains specific antibodies which have the power of neutralizing tetanus toxins.

[Indications]The product is used for therapy of tetanus.

[Quality Standard]CP2015

[Specifications]10000IU/2.5ml